- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasms, Prostate in United Kingdom
Total 49812 results
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
University of ChicagoVisualase, Inc.Completed
-
GenVecNational Institutes of Health (NIH)UnknownLocally Advanced Prostate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstate CancerBelgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Stage D0 Prostate CancerUnited States
-
Northwestern UniversityNorthShore University HealthSystemCompletedProstate CancerUnited States
-
University of MiamiCompletedProstate Cancer | Prostate Adenocarcinoma | Radiation ToxicityUnited States
-
Donald Trump, MDTerminated
-
Burzynski Research InstituteWithdrawnStage IV Prostate CancerUnited States
-
Temple UniversityCompleted
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
University of FloridaCureVacTerminated
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Virginia Commonwealth UniversityWithdrawnProstate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
Daniel George, MDNovartis PharmaceuticalsCompletedHormone Refractory Prostate CancerUnited States
-
Veterans Medical Research FoundationUniversity of California, San Diego; Alliant International UniversityCompleted
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
Daniel VaenaCompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Won KimNovartisTerminated
-
NanOlogy, LLCUS Biotest, Inc.CompletedAdenocarcinoma of the ProstateUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Completed
-
Emory UniversityCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Burzynski Research InstituteWithdrawnRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
-
Mamta ParikhNational Cancer Institute (NCI); PandomedxCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States
-
M.D. Anderson Cancer CenterCompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
University of HawaiiGenentech, Inc.; DendreonCompletedProstate Cancer MetastaticUnited States
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Bellicum PharmaceuticalsCompletedCastrate Resistent Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
AstraZenecaCompletedAdvanced Prostate AdenocarcinomaUnited States
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States